Insiders · TXG

TXG insider transactions

10x Genomics Inc. (TXG) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

TXG insiders

Everyone who has filed a Form 3, 4, 5 or 144 at 10x Genomics Inc., latest first. Follow anyone to get their next filing.

• Serge SaxonovChief Executive Officer, Director-$43.1M
• Ansuman SatpathyDirector, since October 2026
• Joseph E GilliamDirector, since October 2026
• Shehnaaz SulimanDirector-$792K
• Adam TaichChief Financial Officer, since August 2024-$5.18M
• John R StuelpnagelDirector-$25.8M
• Benjamin J. HindsonOfficer, Director-$87.1M
• Sarah A. TeichmannDirector, since July 2024-$579K
• Kimberly J PopovitsDirector
• Alan MateoDirector, since June 2024+$446K
• Sridhar KosarajuDirector-$2.31M
• Justin J. McAnearFormer Chief Financial Officer+$6,397-$21.1M
• Mathai MammenDirector-$1.74M
• James WilburOfficer, since July 2022-$1.23M
• Bryan E RobertsDirector
• Bradford CrutchfieldInsider+$6,397-$32.2M
• Paladin Capital Management, LLC10% owner-$78.3M

Recent Form 3, 4, and 5 filings for TXG

• 1h
  Chief Executive Officer Saxonov Serge sold $1,949,900 worth of shares (31,000 units at $62.90), decreasing direct ownership by 3% to 1,019,249 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 7d
  SEC Form 3 filed by new insider Satpathy Ansuman

  3 - 10x Genomics, Inc. (0001770787) (Issuer)
• 7d
  New insider Gilliam Joseph E claimed ownership of 31 shares (SEC Form 3)

  3 - 10x Genomics, Inc. (0001770787) (Issuer)
• 50d
  Director Suliman Shehnaaz sold $464,668 worth of shares (5,723 units at $81.19) as part of a pre-agreed trading plan, decreasing direct ownership by 19% to 23,792 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 50d
  Chief Executive Officer Saxonov Serge sold $2,030,562 worth of shares (25,000 units at $81.22) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,050,249 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 63d
  Chief Financial Officer Taich Adam sold $2,995,470 worth of shares (46,388 units at $64.57) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 316,344 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 66d
  Director Stuelpnagel John R sold $1,235,072 worth of shares (20,000 units at $61.75), decreasing direct ownership by 6% to 328,436 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 71d
  Chief Executive Officer Saxonov Serge gifted 100 shares, decreasing direct ownership by 0.01% to 1,075,249 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 77d
  Chief Executive Officer Saxonov Serge sold $667,901 worth of shares (10,486 units at $63.69) as part of a pre-agreed trading plan, decreasing direct ownership by 0.97% to 1,075,349 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 79d
  Chief Executive Officer Saxonov Serge sold $1,168,775 worth of shares (18,545 units at $63.02), decreasing direct ownership by 2% to 1,085,835 units (SEC Form 4) to satisfy tax liability

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 79d
  Chief Financial Officer Taich Adam sold $1,081,853 worth of shares (17,166 units at $63.02), decreasing direct ownership by 5% to 362,732 units (SEC Form 4) to cover withholding tax

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 79d
  Officer Hindson Benjamin J. sold $870,860 worth of shares (13,818 units at $63.02), decreasing direct ownership by 3% to 488,182 units (SEC Form 4) (withholding obligation)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 79d
  Director Suliman Shehnaaz sold $140,478 worth of shares (2,207 units at $63.65) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 29,515 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 81d
  Chief Executive Officer Saxonov Serge gifted 4,000 shares, decreasing direct ownership by 0.36% to 1,104,380 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 88d
  Director Teichmann Sarah A. sold $432,279 worth of shares (7,551 units at $57.25) as part of a pre-agreed trading plan, decreasing direct ownership by 21% to 28,058 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 92d
  Director Stuelpnagel John R sold $1,155,055 worth of shares (20,000 units at $57.75), decreasing direct ownership by 5% to 348,436 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 142d
  Chief Executive Officer Saxonov Serge sold $1,033,269 worth of shares (30,000 units at $34.44) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,108,380 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 148d
  Director Suliman Shehnaaz sold $186,756 worth of shares (5,723 units at $32.63) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 31,722 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 158d
  Director Teichmann Sarah A. was granted 8,829 shares, increasing direct ownership by 33% to 35,609 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 158d
  Director Suliman Shehnaaz was granted 8,829 shares, increasing direct ownership by 31% to 37,445 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 158d
  Director Stuelpnagel John R was granted 8,829 shares, increasing direct ownership by 2% to 368,436 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 158d
  Director Popovits Kimberly J was granted 8,829 shares, increasing direct ownership by 31% to 37,445 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 158d
  Director Mateo Alan was granted 8,829 shares, increasing direct ownership by 11% to 85,877 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 158d
  Director Kosaraju Sridhar was granted 8,829 shares, increasing direct ownership by 16% to 65,278 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 170d
  Chief Executive Officer Saxonov Serge sold $709,057 worth of shares (28,893 units at $24.54) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,138,380 units (SEC Form 4) to satisfy withholding tax

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 170d
  Officer Hindson Benjamin J. sold $283,399 worth of shares (11,595 units at $24.44), decreasing direct ownership by 2% to 502,000 units (SEC Form 4) to satisfy tax liability

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 170d
  Chief Financial Officer Taich Adam sold $369,018 worth of shares (15,098 units at $24.44), decreasing direct ownership by 4% to 379,898 units (SEC Form 4) to cover taxes

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 211d
  SEC Form 4 filed by Saxonov Serge

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 233d
  SEC Form 4 filed by Saxonov Serge

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 254d
  Chief Executive Officer Saxonov Serge gifted 2,750 shares and sold $367,097 worth of shares (16,152 units at $22.73), decreasing direct ownership by 2% to 1,200,917 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 256d
  Chief Executive Officer Saxonov Serge was granted 157,895 shares, increasing direct ownership by 15% to 1,219,819 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 256d
  Officer Hindson Benjamin J. was granted 88,816 shares, increasing direct ownership by 21% to 513,595 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 256d
  Chief Financial Officer Taich Adam was granted 106,579 shares, increasing direct ownership by 37% to 394,996 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 259d
  Director Teichmann Sarah A. sold $147,108 worth of shares (7,579 units at $19.41), decreasing direct ownership by 22% to 26,780 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 261d
  Chief Executive Officer Saxonov Serge sold $178,928 worth of shares (9,632 units at $18.58), decreasing direct ownership by 0.90% to 1,061,924 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 261d
  Chief Financial Officer Taich Adam sold $166,593 worth of shares (8,968 units at $18.58), decreasing direct ownership by 3% to 288,417 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 261d
  Officer Hindson Benjamin J. sold $145,379 worth of shares (7,826 units at $18.58), decreasing direct ownership by 2% to 424,779 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 310d
  Chief Executive Officer Saxonov Serge exercised 50,000 shares at a strike of $1.20, increasing direct ownership by 5% to 1,071,556 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 353d
  Chief Financial Officer Taich Adam sold $225,852 worth of shares (11,888 units at $19.00), decreasing direct ownership by 4% to 297,385 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 353d
  Officer Hindson Benjamin J. sold $157,363 worth of shares (8,283 units at $19.00), decreasing direct ownership by 2% to 432,605 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 353d
  Chief Executive Officer Saxonov Serge sold $251,936 worth of shares (13,261 units at $19.00), decreasing direct ownership by 1% to 1,021,556 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 423d
  Chief Executive Officer Saxonov Serge gifted 900 shares, decreasing direct ownership by 0.09% to 1,034,817 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 444d
  Chief Executive Officer Saxonov Serge sold $128,881 worth of shares (9,348 units at $13.79), decreasing direct ownership by 0.98% to 945,892 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 444d
  Chief Financial Officer Taich Adam sold $307,657 worth of shares (22,315 units at $13.79), decreasing direct ownership by 7% to 309,273 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 444d
  Officer Hindson Benjamin J. sold $103,209 worth of shares (7,486 units at $13.79), decreasing direct ownership by 2% to 440,888 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 520d
  Chief Executive Officer Saxonov Serge gifted 1,000 shares, decreasing direct ownership by 0.10% to 955,240 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 526d
  Director Teichmann Sarah A. was granted 15,357 shares, increasing direct ownership by 81% to 34,359 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 526d
  Director Suliman Shehnaaz was granted 15,357 shares, increasing direct ownership by 116% to 28,616 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 526d
  Director Stuelpnagel John R was granted 15,357 shares, increasing direct ownership by 4% to 359,607 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 526d
  Director Popovits Kimberly J was granted 15,357 shares, increasing direct ownership by 116% to 28,616 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 526d
  Director Mateo Alan was granted 15,357 shares, increasing direct ownership by 25% to 77,048 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 526d
  Director Kosaraju Sridhar was granted 15,357 shares, increasing direct ownership by 37% to 56,449 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 529d
  Chief Executive Officer Saxonov Serge gifted 3,000 shares, decreasing direct ownership by 0.28% to 1,080,625 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 535d
  Chief Executive Officer Saxonov Serge sold $77,540 worth of shares (9,343 units at $8.30), decreasing direct ownership by 0.85% to 1,083,625 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 535d
  Officer Hindson Benjamin J. sold $62,120 worth of shares (7,485 units at $8.30), decreasing direct ownership by 2% to 448,374 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 535d
  Chief Financial Officer Taich Adam sold $33,562 worth of shares (4,044 units at $8.30), decreasing direct ownership by 1% to 331,588 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 604d
  Chief Executive Officer Saxonov Serge was granted 171,428 shares, increasing direct ownership by 19% to 1,092,968 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 604d
  Officer Hindson Benjamin J. was granted 120,535 shares, increasing direct ownership by 36% to 455,859 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 604d
  Chief Financial Officer Taich Adam was granted 335,632 shares (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)
• 618d
  Chief Executive Officer Saxonov Serge sold $84,393 worth of shares (7,942 units at $10.63) and exercised 50,000 shares at a strike of $1.20, increasing direct ownership by 5% to 921,540 units (SEC Form 4)

  4 - 10x Genomics, Inc. (0001770787) (Issuer)